ÌÇÐÄÊÓÆµ

July 14, 2025

Neanderthal gene variant lowers muscle enzyme activity in modern humans

Credit: Pixabay/CC0 Public Domain
× close
Credit: Pixabay/CC0 Public Domain

The enzyme AMPD1 plays a key role in muscle energy production and normal muscular function. Loss of AMPD1 activity due to genetic mutations is the most common cause of metabolic myopathy in Europeans, occurring at a frequency of 9% to 14%.

In a study in Nature Communications, researchers compared ancient Neanderthal DNA with modern human genomes and found that all Neanderthals carried a specific AMPD1 variant absent in other species. Laboratory-produced enzymes with this variant showed a 25% reduction in AMPD1 activity. When introduced into genetically engineered mice, the reduction reached 80% in muscle tissue, impairing enzyme function.

The study also revealed that modern humans inherited this variant through interbreeding with Neanderthals, who inhabited Europe and Western Asia before encountering modern humans about 50,000 years ago. Today, individuals of non-African descent carry roughly 1% to 2% Neanderthal DNA.

The Neanderthal AMPD1 variant is carried by 2% to 8% of Europeans today, suggesting that it is generally tolerated.

Amino acid differences between modern humans and Neandertals in enzymes involved in purine metabolism. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-61605-4
× close
Amino acid differences between modern humans and Neandertals in enzymes involved in purine metabolism. Credit: Nature Communications (2025). DOI: 10.1038/s41467-025-61605-4

"Strikingly, most individuals who carry the variant do not experience significant health issues. However, the enzyme appears to play an important role in ," explains Dominik Macak, the study's first author. An analysis of more than 1,000 across various sports revealed that individuals who carry a non-functional AMPD1 are less likely to become top-level athletes.

Get free science updates with Science X Daily and Weekly Newsletters — to customize your preferences!

"Carrying a broken AMPD1 enzyme, the likelihood of reaching athletic performance is reduced by half," Macak adds.

In summary, although AMPD1 activity appears to have only moderate relevance in contemporary Western societies, it is important under extreme physical conditions, such as those experienced by athletes. The researchers emphasize the importance of studying genetic variants in their physiological and evolutionary contexts in order to understand their biological effects.

"It's possible that cultural and in both and Neanderthals reduced the need for extreme muscle performance," says senior author Hugo Zeberg.

Understanding how ancient gene variants affect human physiology today can provide valuable insights into health, performance, and genetic diversity.

More information: Dominik Macak et al, Muscle AMP deaminase activity was lower in Neandertals than in modern humans, Nature Communications (2025).

Journal information: Nature Communications

Provided by Max Planck Society

Load comments (2)

This article has been reviewed according to Science X's and . have highlighted the following attributes while ensuring the content's credibility:

fact-checked
peer-reviewed publication
trusted source
proofread

Get Instant Summarized Text (GIST)

A Neanderthal-derived AMPD1 gene variant, present in 2% to 8% of Europeans, reduces muscle enzyme activity by up to 80% in muscle tissue. While most carriers do not experience major health issues, this variant is linked to a significantly lower likelihood of achieving elite athletic performance, highlighting its impact under extreme physical conditions.

This summary was automatically generated using LLM.